前瞻性视网膜临床试验中的不依从:预测失访因素的分析
该研究回顾性分析了10项研究者发起的随机临床试验中390名受试者的不依从情况,涉及增殖性糖尿病视网膜病变、新生血管性年龄相关性黄斑变性、糖尿病黄斑水肿和视网膜静脉阻塞性疾病。结果显示212名(54.4%)完全依从,178名(45.6%)符合不依从标准,其中53名(13.6%)提前退出。回归模型识别出17个与不依从显著相关的变量,距离、合并症、糖尿病状态、合并用药、既往就诊次数、研究时长、研究疾病和严重不良事件为高度显著风险因素。
要点
- 390名受试者中178名(45.6%)符合不依从标准,53名(13.6%)提前退出。
- 回归模型识别出17个显著影响不依从的变量。
- 距离、合并症、糖尿病状态、合并用药、既往就诊次数、研究时长、研究疾病和严重不良事件为高度显著风险因素。
核心结论
- 当前研究在分析试验中识别出相当比例符合不依从标准的受试者。
- 所识别因素与已发表临床观察和既往临床试验结果一致。
- 结果强调在设计前瞻性临床试验时考虑研究设计和病史以减少数据丢失的重要性。
研究设计与样本
- 回顾性分析10项随机临床试验。
- 受试者纳入研究者发起的试验,研究增殖性糖尿病视网膜病变、新生血管性年龄相关性黄斑变性、糖尿病黄斑水肿和视网膜静脉阻塞性疾病。
- 回顾性审查记录以评估假设的不依从风险因素和不依从率,不依从定义为至少1次错过访视或提前退出研究。
- 使用Student t检验、Pearson χ2检验和逻辑回归分析人口学信息、全身病史和眼部病史(包括视力和中心视网膜厚度)。
主要发现
- 纳入390名受试者,212名(54.4%)对所有计划研究访视依从,178名(45.6%)符合不依从标准,53名(13.6%)提前退出。
- 回归模型识别出17个在决定受试者不依从方面显著的变量。
- 距离、合并症、糖尿病状态、合并用药、既往就诊次数、研究时长、研究疾病和严重不良事件为高度显著的不依从风险因素。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Noncompliance during prospective studies can bias results and limit conclusions. The current study retrospectively investigated the relationship between study subject characteristics and rates of noncompliance in interventional trials involving common causes of blindness. DESIGN: Retrospective analysis of 10 randomized clinical trials. METHODS: Subjects were enrolled in investigator-initiated trials studying proliferative diabetic retinopathy, neovascular age-related macular degeneration, diabetic macular edema, and retinal venous occlusive disease. Records were reviewed for hypothesized risk factors of noncompliance and rates of noncompliance, which were defined as at least 1 missed visit or exiting the study early. Demographic information, systemic medical history, and ocular medical history, including visual acuity and central retinal thicknesses, were examined retrospectively using Student t test, Pearson χ2 test, and logistic regression. RESULTS: Of 390 subjects included, 212 (54.4%) were compliant with all scheduled study visits and 178 (45.6%) met criteria for noncompliance, with 53 (13.6%) subjects exiting early. Regression models identified 17 variables that were significant in determining subject noncompliance. Among those, distance, comorbidities, diabetic status, concomitant medications, previous clinic visits, length of study, disease under study, and severe adverse events were highly significant risk factors of noncompliance. CONCLUSION: The current research identified a substantial proportion of subjects who met the criteria for noncompliance within the trials analyzed. The factors identified in the current work are consistent with published clinical observations and the results of previous clinical trials. These results highlight the importance of considering study design and medical history when designing prospective clinical trials in an attempt to minimize data loss.
引用
- Zhou B, Mitchell TC, Rusakevich AM, et al. Noncompliance in Prospective Retina Clinical Trials: Analysis of Factors Predicting Loss to Follow-up. Am J Ophthalmol. 2019. PMID: 31647931. doi:10.1016/j.ajo.2019.10.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。